Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |